RAMSAY SANTE : availability of the Universal Registration Document 2025
PRESS RELEASE Paris, 29th October 2025 AVAILABILITY OF THE UNIVERSAL REGISTRATION DOCUMENT 2025…
EmblemHealth and Prime Therapeutics Pioneer New Pharmacy Benefit Collaboration
NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- EmblemHealth, one of the…
Tevogen Senior Management Engages with Business and Community Leaders and Highlights Recent Progress
WARREN, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings…
Canadian Red Cross opens appeal to help people impacted by Hurricane Melissa
OTTAWA, Oct. 28, 2025 (GLOBE NEWSWIRE) -- The Canadian Red Cross has…
Anteris DurAVR THV Demonstrates Favorable Hemodynamics in Small Annuli Patients with no Valve Related Mortality at One Year
MINNEAPOLIS and BRISBANE, Australia, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies…
SonderCare Launches Impulse Essential 39 Residential Comfort Bed, Expanding Affordable Luxury Homecare Options in the United States
Introducing a new standard in entry-level homecare beds — SonderCare’s Impulse Essential…
Varonis Announces $150 Million Share Repurchase Authorization
October 28, 2025 16:05 ET | Source: Varonis Systems, Inc. MIAMI, Oct.…
Landmark Study Demonstrates Sustained Clinical Benefits of Flexitouch Plus as First-Line Therapy in Treating Head and Neck Cancer-Related Lymphedema
October 28, 2025 16:05 ET | Source: Tactile Systems Technology, Inc. MINNEAPOLIS,…
Varonis Announces Third Quarter 2025 Financial Results
Annual recurring revenues increased 18% year-over-yearSaaS ARR as a percentage of total…
Anteris Technologies Announces First Patients Treated in DurAVR THV Global Pivotal Trial (the PARADIGM Trial)
MINNEAPOLIS, United States and BRISBANE, Australia, Oct. 27, 2025 (GLOBE NEWSWIRE) --…
